Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Film studio Miramax explores sale: sources

Published 07/17/2015, 07:01 PM
Updated 07/17/2015, 07:05 PM
© Reuters. Actor McKellen arrives for screening at 65th Berlinale International Film Festival in Berlin

By Liana B. Baker

(Reuters) - Privately-held Miramax, which owns the rights to hundreds of Hollywood films including "Bridget Jones' Diary" and "The English Patient," is exploring strategic alternatives including a potential sale, according to people familiar with the matter.

The Santa Monica, California-based company is speaking to financial advisers about its options, according to the people, who could not be named because the matter is private.

Bloomberg, which first reported the news Friday, said the company could be valued as high as $1 billion. A spokesman for Miramax declined to comment.

An investor group including Qatar Holding and Thomas J. Barrack Jr.'s investment firm Colony Capital bought the company from Disney in 2010 for $660 million.

While the company is best known for its extensive film library, it now has started to distribute new movies, including independent film "Mr. Holmes," starring Sir Ian McKellen and Laura Linney which was released on Friday.

It also produces a TV show called "From Dusk Till Dawn" which is based on the 1996 Robert Rodriguez film.

© Reuters. Actor McKellen arrives for screening at 65th Berlinale International Film Festival in Berlin

Miramax was founded in 1979 by Bob and Harvey Weinstein.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.